检验医学 ›› 2014, Vol. 29 ›› Issue (2): 125-129.DOI: 10.3969/j.issn.1673-8640.2014.02.009

• 临床应用研究·论著 • 上一篇    下一篇

高同型半胱氨酸血症患者氧化应激指标的研究

蒋兴亮, 刘素兰, 易婷婷   

  1. 川北医学院附属医院检验科, 四川 南充 637000
  • 收稿日期:2013-02-04 出版日期:2014-02-20 发布日期:2014-02-20
  • 作者简介:蒋兴亮, 男, 1963年生, 学士, 主任技师, 主要从事临床化学检验工作。
  • 基金资助:

    四川省卫生厅资助项目(20090142)

Research on the parameters of oxidative stress in patients with hyperhomocysteinemia

JIANG Xingliang, LIU Sulan, YI Tingting.   

  1. Department of Clinical Laboratory, the Affiliated Hospital of North Sichuan Medical College, Sichuan Nanchong 637000, China
  • Received:2013-02-04 Online:2014-02-20 Published:2014-02-20

摘要:

目的 观察高同型半胱氨酸血症(HHcy)患者氧化应激指标的水平, 并对其临床价值做初步评价。方法 检测108例HHcy患者、106名健康体检者(正常对照组)循环谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、对氧磷酯酶1(PON1)、一氧化氮合酶(NOS)活性及同型半胱氨酸( Hcy)、一氧化氮(NO)和丙二醛(MDA)水平。分析Hcy与GSH-Px、SOD、PON1、NOS、NO、MDA之间的相关性。结果 HHcy患者血浆MDA水平[(6.23±1.55)μmol/L]明显高于正常对照组[(4.14±1.13)μmol/L](P<0.01), 而GSH-Px [(189.3±25.1)U/L]、SOD[(77.3±20.5)NU/mL]、PON1[(133.6±23.9)kU/L]、NOS活性[(25.3±2.9)U/mL]及NO[(68.3±10.1)μmol/L]水平低于正常对照组[(240.3±78.1)U/L、(89.2±24.8)NU/mL、(168.2±26.0)kU/L、(30.0±3.3)U/mL、(92.1±12.1)μmol/L](P均<0.01)。HHcy患者血浆Hcy与MDA呈正相关(r=0.72, P<0.01), 与GSH-Px、SOD、PON1、NOS、NO呈明显负相关(r值分别为-0.60、-0.49、-0.51、-0.43、-0.50, P均<0.01)。结论 HHcy患者氧化应激增强可能与Hcy氧化过程中产生过多的过氧化物及活性氧、Hcy损伤NO/L-精氨酸系统及直接抵制抗氧化酶活性有关。Hcy可能通过增加氧化应激和降低抗氧化能力在动脉粥样硬化发生、发展中起重要的作用。

关键词: 氧化应激, 高同型半胱氨酸血症, 对氧磷酯酶1

Abstract:

Objective To observe the parameters of oxidative stress in patients with hyperhomocysteinemia (HHcy), and to evaluate the clinical significance primarily. Methods A total of 108 HHcy patients and 106 healthy subjects (healthy control group) were enrolled for determining the activities of glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), paraoxonase 1 (PON1) and nitric oxide synthase (NOS) and the levels of homocysteine (Hcy), nitric oxide (NO) and malondialdehyde (MDA). The correlations of Hcy with GSH-Px, SOD, PON1, NOS, NO and MDA were analyzed. Results The MDA level in patients with HHcy [(6.23±1.55) μmol/L] was higher than that in healthy control group [(4.14±1.13) μmol/L](P<0.01). The GSH-Px [(189.3±25.1) U/L], SOD [(77.3±20.5) NU/mL], PON1 [(133.6±23.9) kU/L], NOS [(25.3±2.9) U/mL] and NO [(68.3±10.1) μmol/L] in patients with HHcy were lower than those in healthy control group [(240.3±78.1) U/L, (89.2±24.8) NU/mL, (168.2±26.0) kU/L, (30.0±3.3) U/mL and (92.1±12.1) μmol/L] (P<0.01). The correlation of Hcy with MDA was positive, and negative with GSH-Px, SOD, PON1, NOS and NO (r=-0.60, -0.49, -0.51, -0.43 and -0.50, P<0.01). Conclusions Oxidative stress in patients with HHcy is related with pro-oxidant and antioxidant imbalance, Hcy impairment NO/L-arginine system and antioxidase activity defense systems. Hcy plays a role in the pathogenesis and development of atherosclerosis by increasing the oxidative stress and decreasing the ability of antioxidation.

Key words: Oxidative stress, Hyperhomocysteinemia, Paraoxonase 1

中图分类号: